SCPH Annual Working Capital
$79.80 M
-$36.09 M-31.14%
31 December 2023
Summary:
As of January 23, 2025, SCPH annual working capital is $79.80 million, with the most recent change of -$36.09 million (-31.14%) on December 31, 2023. During the last 3 years, it has fallen by -$18.70 million (-18.98%). SCPH annual working capital is now -31.14% below its all-time high of $115.89 million, reached on December 31, 2022.SCPH Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCPH Quarterly Working Capital
$108.06 M
+$58.36 M+117.43%
30 September 2024
Summary:
As of January 23, 2025, SCPH quarterly working capital is $108.06 million, with the most recent change of +$58.36 million (+117.43%) on September 30, 2024. Over the past year, it has increased by +$28.26 million (+35.41%). SCPH quarterly working capital is now -9.14% below its all-time high of $118.93 million, reached on March 31, 2023.SCPH Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCPH Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -31.1% | +35.4% |
3 y3 years | -19.0% | -6.8% |
5 y5 years | -6.4% | -6.8% |
SCPH Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -31.1% | +25.8% | -9.1% | +260.3% |
5 y | 5-year | -31.1% | +25.8% | -9.1% | +260.3% |
alltime | all time | -31.1% | >+9999.0% | -9.1% | +276.4% |
ScPharmaceuticals Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $108.06 M(+117.4%) |
June 2024 | - | $49.70 M(-22.6%) |
Mar 2024 | - | $64.21 M(-19.5%) |
Dec 2023 | $79.80 M(-31.1%) | $79.80 M(-14.5%) |
Sept 2023 | - | $93.39 M(-12.7%) |
June 2023 | - | $106.94 M(-10.1%) |
Mar 2023 | - | $118.93 M(+2.6%) |
Dec 2022 | $115.89 M(+82.7%) | $115.89 M(+286.4%) |
Sept 2022 | - | $29.99 M(-29.1%) |
June 2022 | - | $42.31 M(-21.7%) |
Mar 2022 | - | $54.05 M(-14.8%) |
Dec 2021 | $63.43 M(-35.6%) | $63.43 M(-12.2%) |
Sept 2021 | - | $72.27 M(-10.3%) |
June 2021 | - | $80.60 M(-9.9%) |
Mar 2021 | - | $89.42 M(-9.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $98.50 M(+39.9%) | $98.50 M(-9.2%) |
Sept 2020 | - | $108.49 M(-7.0%) |
June 2020 | - | $116.61 M(+56.7%) |
Mar 2020 | - | $74.41 M(+5.7%) |
Dec 2019 | $70.41 M(-17.4%) | $70.41 M(-8.3%) |
Sept 2019 | - | $76.78 M(+12.5%) |
June 2019 | - | $68.24 M(-9.9%) |
Mar 2019 | - | $75.72 M(-11.2%) |
Dec 2018 | $85.22 M(-25.7%) | $85.22 M(-4.7%) |
Sept 2018 | - | $89.40 M(-6.4%) |
June 2018 | - | $95.50 M(-9.7%) |
Mar 2018 | - | $105.77 M(-7.8%) |
Dec 2017 | $114.67 M(+218.5%) | $114.67 M(+299.5%) |
Sept 2017 | - | $28.71 M(-20.3%) |
Dec 2016 | $36.00 M(<-9900.0%) | $36.00 M |
Dec 2015 | -$187.00 K | - |
FAQ
- What is scPharmaceuticals annual working capital?
- What is the all time high annual working capital for scPharmaceuticals?
- What is scPharmaceuticals annual working capital year-on-year change?
- What is scPharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for scPharmaceuticals?
- What is scPharmaceuticals quarterly working capital year-on-year change?
What is scPharmaceuticals annual working capital?
The current annual working capital of SCPH is $79.80 M
What is the all time high annual working capital for scPharmaceuticals?
scPharmaceuticals all-time high annual working capital is $115.89 M
What is scPharmaceuticals annual working capital year-on-year change?
Over the past year, SCPH annual working capital has changed by -$36.09 M (-31.14%)
What is scPharmaceuticals quarterly working capital?
The current quarterly working capital of SCPH is $108.06 M
What is the all time high quarterly working capital for scPharmaceuticals?
scPharmaceuticals all-time high quarterly working capital is $118.93 M
What is scPharmaceuticals quarterly working capital year-on-year change?
Over the past year, SCPH quarterly working capital has changed by +$28.26 M (+35.41%)